CurevacNL0015436031CVACCVAC
Curevac
NL0015436031
CVAC
CVAC
Financials
Market Cap
$702.08M5Y beta
2.53EPS (TTM)
-$1.269Free Float
122.58MRevenue (TTM)
$57.83MEBITDA (TTM)
-$270.57MFree Cashflow (TTM)
-$347.58MPricing
1D span
$2.946$3.227
52W span
$2.215$12.36
Analyst Ratings
The price target is $9.086 and the stock is covered by 9 analysts.
Buy
5
Hold
3
Sell
1
Information
999Biotechnology & DrugsHealth Care
CureVac AG is a clinical-stage biopharmaceutical company, The Company strives to create transformative medicines to protect and improve people’s lives. Fueled by proprietary RNA technology platform combined with two decades of science and manufacturing, The Company is dedicated to creating novel treatments that enable the body to make its own prophylactic and therapeutic drugs.
Identifier
ISIN
NL0015436031
Primary Ticker
CVAC